Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization Refractory

BACKGROUND AND AIMS: Patients with intermediate-stage hepatocellular carcinoma (HCC) who are refractory to transarterial chemoembolization (TACE) have a poor prognosis. This study aimed to explore whether stereotactic body radiation therapy (SBRT) combined with PD-1 inhibitors could improve the clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yan-Jun, Wang, Kang, Zheng, Yi-Tao, Feng, Shuang, Yu, Hong-Ming, Li, Xiao-Wei, Cheng, Xi, Cheng, Yu-Qiang, Feng, Jin-Kai, Zhou, Li-Ping, Meng, Yan, Zhai, Jian, Shan, Yun-Feng, Cheng, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978966/
https://www.ncbi.nlm.nih.gov/pubmed/35387113
http://dx.doi.org/10.3389/fonc.2022.839605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978966/
https://www.ncbi.nlm.nih.gov/pubmed/35387113
http://dx.doi.org/10.3389/fonc.2022.839605

Ejemplares similares